These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 16781126)

  • 1. Comparison of neurofuzzy logic and neural networks in modelling experimental data of an immediate release tablet formulation.
    Shao Q; Rowe RC; York P
    Eur J Pharm Sci; 2006 Aug; 28(5):394-404. PubMed ID: 16781126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of neurofuzzy logic and decision trees in discovering knowledge from experimental data of an immediate release tablet formulation.
    Shao Q; Rowe RC; York P
    Eur J Pharm Sci; 2007 Jun; 31(2):129-36. PubMed ID: 17459671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advantages of neurofuzzy logic against conventional experimental design and statistical analysis in studying and developing direct compression formulations.
    Landín M; Rowe RC; York P
    Eur J Pharm Sci; 2009 Nov; 38(4):325-31. PubMed ID: 19716414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimisation of the predictive ability of artificial neural network (ANN) models: a comparison of three ANN programs and four classes of training algorithm.
    Plumb AP; Rowe RC; York P; Brown M
    Eur J Pharm Sci; 2005; 25(4-5):395-405. PubMed ID: 15893460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneous fuzzy logic networks: fundamentals and development studies.
    Pedrycz W
    IEEE Trans Neural Netw; 2004 Nov; 15(6):1466-81. PubMed ID: 15565774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minimisation of the capping tendency by tableting process optimisation with the application of artificial neural networks and fuzzy models.
    Belic A; Skrjanc I; Bozic DZ; Karba R; Vrecer F
    Eur J Pharm Biopharm; 2009 Sep; 73(1):172-8. PubMed ID: 19465122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of an artificial intelligence technology--Model trees. Novel applications for an immediate release tablet formulation database.
    Shao Q; Rowe RC; York P
    Eur J Pharm Sci; 2007 Jun; 31(2):137-44. PubMed ID: 17452096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tuning neural and fuzzy-neural networks for toxicity modeling.
    Mazzatorta P; Benfenati E; Neagu CD; Gini G
    J Chem Inf Comput Sci; 2003; 43(2):513-8. PubMed ID: 12653515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modelling formulations using gene expression programming--a comparative analysis with artificial neural networks.
    Colbourn EA; Roskilly SJ; Rowe RC; York P
    Eur J Pharm Sci; 2011 Oct; 44(3):366-74. PubMed ID: 21903163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modelling drug dissolution from controlled release products using genetic programming.
    Do DQ; Rowe RC; York P
    Int J Pharm; 2008 Mar; 351(1-2):194-200. PubMed ID: 18053658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of sustained release formulation of an antithrombotic drug and application of Fuzzy logic.
    Tan C; Degim İT
    Pharm Dev Technol; 2012; 17(2):242-50. PubMed ID: 21062232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GFAM: evolving Fuzzy ARTMAP neural networks.
    Al-Daraiseh A; Kaylani A; Georgiopoulos M; Mollaghasemi M; Wu AS; Anagnostopoulos G
    Neural Netw; 2007 Oct; 20(8):874-92. PubMed ID: 17851035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparing the performance of multilayer perceptrons networks and neuro-fuzzy systems for on-line inference of Bacillus megaterium cellular concentrations.
    Nucci ER; Silva RG; Souza VR; Giordano RL; Giordano RC; Cruz AJ
    Bioprocess Biosyst Eng; 2007 Nov; 30(6):429-38. PubMed ID: 17609985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A method for creating fuzzy neural-network models using the MATLAB package for biomedical applications].
    Zhilin VV; Filist SA; Rakhim KA; Shatalova OV
    Med Tekh; 2008; (2):15-8. PubMed ID: 18507134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of pellet properties with use of artificial neural networks.
    Mendyk A; Kleinebudde P; Thommes M; Yoo A; Szlęk J; Jachowicz R
    Eur J Pharm Sci; 2010 Nov; 41(3-4):421-9. PubMed ID: 20659554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurofuzzy systems for the prediction of outcome in acute lower gastrointestinal hemorrhage.
    Tez M; Tez S
    Eur J Gastroenterol Hepatol; 2008 Aug; 20(8):813. PubMed ID: 18617790
    [No Abstract]   [Full Text] [Related]  

  • 17. Formulation of a extended release tablet containing dexibuprofen.
    Yi HG; Chi MH; Kim YI; Woo JS; Park ES
    Arch Pharm Res; 2008 Dec; 31(12):1637-43. PubMed ID: 19099235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of dynamic neural networks in the modeling of drug release from polyethylene oxide matrix tablets.
    Petrović J; Ibrić S; Betz G; Parojcić J; Durić Z
    Eur J Pharm Sci; 2009 Sep; 38(2):172-80. PubMed ID: 19632323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pipelining of Fuzzy ARTMAP without matchtracking: correctness, performance bound, and Beowulf evaluation.
    Castro J; Secretan J; Georgiopoulos M; DeMara R; Anagnostopoulos G; Gonzalez A
    Neural Netw; 2007 Jan; 20(1):109-28. PubMed ID: 17145166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Piecewise-linear neural networks and their relationship to rule extraction from data.
    Holena M
    Neural Comput; 2006 Nov; 18(11):2813-53. PubMed ID: 16999580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.